s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
8-K
Current report filing
Filed
Monday, September 21, 2020
Period
Sep 21, 2020
Accession number
0001564590-20-044129
Documents
8-K
8-K
EX-99.1
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header